DIALYSIS · CCN 452552

DaVita Texarkana Regional Dialysis

TEXARKANA, TX 75503

DialysisProfitDaVita
$11.2M
TOTAL REVENUE
25.3%
OPERATING MARGIN
2 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$11.2M
Total costs
$8.4M
Operating income (rev − costs)
$2.8M
Operating margin
25.3%
Total charges
$11.0M
Total treatments
27,559
Dialysis stations
38

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.24142—
Fistula Rate
DFC_FISTULA_RATE
48.5177—
Five Star Rating
DFC_FIVE_STAR
2——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.997—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
134.6217—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.55——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
15177—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
23.7949—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
12.6178—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
25.8156—
Standardized ED Visits Ratio
DFC_SEDR
1.07109—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
41.394—